Translational Development Acquisition Corp.

TDACNASDAQFinancial Services● Active

$10.76

+$0.02(+0.19%)

Market Cap$235724689

P/E Ratio—

52W High$10.8

52W Low$10.21

Avg Volume77K

Open$10.75

Beta0.01

Overview

Translational Development Acquisition Corp. (TDAC) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

TDAC · earnings · updated Jun 8, 2026

Latest Earnings

Q2 FY2026Report Date: May 15, 2026

EPS Actual

$0.06

Revenue

—

Fiscal Period

Q2 FY2026

FY ends December

Report Date

May 15, 2026

After Market Close

TDAC reports quarterly as a NASDAQ-listed Shell Companies company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$0.21

Rev. $0.66B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$0.21

Rev. Est.$0.66B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q2 FY2026	May 15, 2026	—	$0.06	—	—	—	—
— Q1 FY2026	Mar 16, 2026	—	$0.07	—	—	—	—
— Q3 FY2021	Sep 30, 2021	—	$0.93	—	$0.03B	—	—
— Q3 FY2021	Aug 16, 2021	—	-$0.23	—	$0.03B	—	—
— Q1 FY2021	Mar 30, 2021	—	$0.02	—	—	—	—
— Q1 FY2021	Mar 15, 2021	—	-$0.03	—	—	—	—
— Q3 FY2020	Sep 30, 2020	—	-$0.05	—	—	—	—
— Q2 FY2020	Jun 30, 2020	—	-$0.04	—	—	—	—

Q2 FY2026

May 15, 2026

EPS Actual

$0.06

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 16, 2026

EPS Actual

$0.07

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2021

Sep 30, 2021

EPS Actual

$0.93

EPS Est.

—

EPS Surpr.

—

Revenue

$0.03B

Q3 FY2021

Aug 16, 2021

EPS Actual

-$0.23

EPS Est.

—

EPS Surpr.

—

Revenue

$0.03B

Q1 FY2021

Mar 30, 2021

EPS Actual

$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2021

Mar 15, 2021

EPS Actual

-$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2020

Sep 30, 2020

EPS Actual

-$0.05

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2020

Jun 30, 2020

EPS Actual

-$0.04

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for TDAC.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2026	May 15, 2026	—	$10.64	$10.64	+0.00%
— Q1 FY2026	Mar 16, 2026	—	$10.54	$10.54	+0.00%
— Q3 FY2021	Sep 30, 2021	—	No price data	$10.01	—
— Q3 FY2021	Aug 16, 2021	—	No price data	$10.01	—
— Q1 FY2021	Mar 30, 2021	—	No price data	$10.01	—
— Q1 FY2021	Mar 15, 2021	—	No price data	$10.01	—
— Q3 FY2020	Sep 30, 2020	—	No price data	$10.01	—
— Q2 FY2020	Jun 30, 2020	—	No price data	$10.01	—

Q2 FY2026+0.00%

Report Date

May 15, 2026

EPS Beat/Miss

—

Price Before

$10.64

Price After

$10.64

Q1 FY2026+0.00%

Report Date

Mar 16, 2026

EPS Beat/Miss

—

Price Before

$10.54

Price After

$10.54

Q3 FY2021—

Report Date

Sep 30, 2021

EPS Beat/Miss

—

Price Before

—

Price After

$10.01

Q3 FY2021—

Report Date

Aug 16, 2021

EPS Beat/Miss

—

Price Before

—

Price After

$10.01

Q1 FY2021—

Report Date

Mar 30, 2021

EPS Beat/Miss

—

Price Before

—

Price After

$10.01

Q1 FY2021—

Report Date

Mar 15, 2021

EPS Beat/Miss

—

Price Before

—

Price After

$10.01

Q3 FY2020—

Report Date

Sep 30, 2020

EPS Beat/Miss

—

Price Before

—

Price After

$10.01

Q2 FY2020—

Report Date

Jun 30, 2020

EPS Beat/Miss

—

Price Before

—

Price After

$10.01

Beat Rate0 / 8 quarters

Largest Move+0.00% (Q2 FY2026)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Translational Development Acquisition Corp. (TDAC) most recently reported earnings on May 15, 2026 for Q2 FY2026, posting EPS of $0.06 (in line with the analyst consensus of —). The next TDAC earnings date is expected around September 1, 2026.

Each quarter, investors track TDAC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. TDAC revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

TDAC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

TDAC earnings · 4 questions

Translational Development Acquisition Corp.'s next earnings report is expected around September 1, 2026. TDAC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; TDAC historically reports after market close (AMC).

TDAC earnings datewhen is TDAC earningsTDAC next earnings datewhen does TDAC report earningsTDAC earnings calendar

▸ Source: FMP · Translational Development Acquisition Corp. SEC filings · US GAAP · Translational Development Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026